# Johnson & Johnson (JNJ) — Q1-2019 Earnings Results

**Report date:** 2019-04-16 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2019

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Up 1.1%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.10 | N/A | +1.72% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized operational efficiency as a key focus area moving forward.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on innovation and operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Johnson & Johnson's strong EPS performance indicates solid profitability, which contributed to a positive stock reaction, with shares rising by 1.1%. The lack of revenue data and guidance leaves some uncertainty, but management's focus on innovation and efficiency suggests a strategic approach to future growth.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2019_